跳至主要内容
临床试验/CTIS2023-503220-76-01
CTIS2023-503220-76-01招募中1 期

Prednisolone administration in women with unexplained REcurrent MIscarriages - LUMC-PREMI

eiden University Medical Center0 个研究点目标入组 490 人开始时间: 2023年7月10日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
490

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Age 18-39, Two or more miscarriages (mola and ectopic pregnancies excluded), No underlying cause was found for miscarriages after examination

排除标准

  • Diabetes with medication, Previous enrollment/ participation in PREMI trial, Contraindication for the use of glucocorticosteroids, Use of medication that interferes with prednisolone (see protocol for list), Instable or exacerbation of auto-immune disease, Use of immune suppressing medication (for any reason), Participation or enrollment in other interventional trial for recurrent miscarriages

研究者

发起方
eiden University Medical Center

相似试验